Related Experiment Video
Updated: Apr 6, 2026

MicroRNA In situ Hybridization for Formalin Fixed Kidney Tissues
Published on: November 30, 2013
[MicroRNAs in kidney fibrosis]
Cynthia Van der Hauwaert1, Grégoire Savary1, Marie-Flore Hennino1
1EA4483, pôle recherche, faculté de médecine de Lille, université de Lille, 1, place de Verdun, 59045 Lille cedex, France.
Abstract:
Renal fibrosis represents the final stage of most chronic kidney diseases and contributes to the progressive and irreversible decline in kidney function with accumulation of extracellular matrix components in the renal parenchyma. The molecular mechanisms governing the renal fibrosis process are complex and remain poorly understood. Recently, the profibrotic role of several microRNAs (miRNAs) has been described in kidney fibrosis. MiRNAs are a new class of, small non-coding RNAs of about 20 nucleotides that act as gene expression negative regulators at the post-transcriptional level. Seminal studies have highlighted the potential importance of miRNA as new therapeutic targets and innovative diagnostic and/or prognostic biomarkers. This review summarizes recent scientific advances on the role played by miRNAs in kidney fibrogenesis and discusses potential clinical applications as well as future research directions.
Insights
MicroRNAs (miRNAs) are key regulators in kidney fibrosis, a major cause of chronic kidney disease. Understanding their role offers new diagnostic and therapeutic strategies for kidney fibrogenesis.
Area of Science:
- Nephrology
- Molecular Biology
- Genetics
Background:
- Renal fibrosis is the final, irreversible stage of chronic kidney diseases.
- It involves extracellular matrix accumulation, impairing kidney function.
- The molecular mechanisms of renal fibrosis are complex and not fully understood.
Purpose of the Study:
- To review the role of microRNAs (miRNAs) in kidney fibrogenesis.
- To discuss the potential of miRNAs as diagnostic and therapeutic targets.
- To explore future research directions in miRNA-mediated kidney fibrosis.
Main Methods:
- Literature review of recent scientific advances.
- Analysis of studies investigating miRNA involvement in kidney fibrosis.
- Synthesis of information on miRNA regulatory functions.
Main Results:
- MicroRNAs (miRNAs) play a significant profibrotic role in kidney fibrosis.
- miRNAs regulate gene expression post-transcriptionally.
- Emerging evidence highlights miRNAs as potential biomarkers and therapeutic targets.
Conclusions:
- MicroRNAs are crucial in kidney fibrogenesis.
- Targeting miRNAs may offer novel therapeutic strategies for chronic kidney diseases.
- Further research is needed to fully elucidate miRNA functions and clinical applications.
Related Concept Videos
Nephrons
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Nephrotic Syndrome I : Introduction
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Acute Kidney Injury II: Pathophysiology

